Keywords
Benign prostatic hyperplasia
Kidney deficiency with blood stasis
Tonifying Qi and activating blood
Submitted : 2025-08-10
Accepted : 2025-08-25
Published : 2025-09-09
Abstract
Benign prostatic hyperplasia (BPH) is a common condition affecting the quality of life and health status of elderly men. Its incidence increases with age and is often accompanied by symptoms such as urinary frequency, urgency, nocturia, difficulty voiding, and even urinary retention. While conventional Western medicine can alleviate symptoms, it frequently carries risks of side effects and disease recurrence. Traditional Chinese Medicine approaches this condition based on the characteristic patterns observed in the elderly population: predominantly deficiency and blood stasis, with chronic conditions leading to blood stasis. The Yiqi Huoxue method—aimed at tonifying Qi and activating blood circulation—has been shown to improve urinary symptoms, enhance quality of life, and promote overall health in elderly BPH patients. This article explores the application of the Yiqi Huoxue therapeutic principle in managing benign prostatic hyperplasia.
References
Song Q, Xiong F, 2025, Social Isolation Status and Influencing Factors of the Elderly in China. Journal of Shanxi Normal University (Social Sciences Edition), 52(4): 69–80.
Huang X, Chen XX, Chen X, et al., 2023, Feasibility of Anterior Lobe-Preserving Transurethral Enucleation and Resection of Prostate on Improving Urinary Incontinence in Patients With Benign Prostatic Hyperplasia: A Retrospective Cohort Study. Medicine (Baltimore), 102(7): e32884.
Gong Y, Yu R, Zhu Y, et al., 2024, Diagnosis and Treatment of Benign Prostatic Hyperplasia Based on the “Meridian Disease Theory”. Chinese Journal of Basic Medicine of Traditional Chinese Medicine, 30(3): 541–544.
Wang Y, Gao X, Zhan X, 2024, Study on the Therapeutic Effect of Medicated Moxibustion Combined With Western Medicine in the Treatment of Benign Prostatic Hyperplasia of Kidney Deficiency and Blood Stasis Type. Zhejiang Journal of Traditional Chinese Medicine, 59(10): 912–914.
Xu Z, Chen R, Qiu J, et al., 2024, Investigation and Analysis on TCM Constitution Identification of Patients With Benign Prostatic Hyperplasia. Chinese Journal of Modern Pharmaceutical Application, 18(24): 125–128.
Wu M, Wang T, Liu S, et al., 2019, Literature Analysis on the Distribution of TCM Syndromes and Elements in Benign Prostatic Hyperplasia Based on the Clinical Experience of Renowned Doctors and Experts. Chinese Journal of Experimental Formulae, 25(20): 173–180.
Li S, Lu G, Jin G, et al., 2024, Progress in Basic and Clinical Research on the Treatment of Benign Prostatic Hyperplasia With Traditional Chinese Medicine. Chinese Journal of Materia Medica, 49(21): 5817–5828.
Li D, 2011, Professor Wang Qi’s Experience in Treating Benign Prostatic Hyperplasia. Chinese Journal of Traditional Chinese Medicine, 26(2): 286–288.
Wang S, Wang B, Xu H, et al., 2022, Professor Li Haisong’s Experience in Treating Benign Prostatic Hyperplasia From the Perspectives of Blood Stasis and Deficiency. Chinese Journal of Andrology, 36(3): 105–108.
Zhang C, Li Y, Li Y, 2018, Professor Li Yueqing’s Clinical Experience in Treating Benign Prostatic Hyperplasia Based on the Theory of Kidney Deficiency and Blood Stasis. Modern Chinese Medicine Clinical Practice, 25(3): 7–10.
Yang K, Yan F, Zhu Y, et al., 2017, Zeng Qingqi’s Three Cases of Treating Male Diseases With Guizhi Fuling Pills. Shandong Journal of Traditional Chinese Medicine, 36(9): 811–812.
Sun Z, Li P, Men B, et al., 2019, Men Chengfu’s Experience in Treating Benign Prostatic Hyperplasia Based on Blood Stasis. Chinese Journal of Traditional Chinese Medicine, 37(10): 2314–2317.
Zhao F, Li H, Zhang C, et al., 2022, Based on the Theory of Kidney Deficiency and Blood Stasis, This Paper Explores the Application and Prospect of the Method of Tonifying the Kidney and Promoting Blood Circulation in Male Diseases. Chinese Journal of Traditional Chinese Medicine, 37(2): 605–611.
Lu L, Xie J, 2023, Clinical Research Progress on the Treatment of Benign Prostatic Hyperplasia With Traditional Chinese Medicine. Journal of Practical Chinese Medicine, 39(9): 1916–1919.
Han X, Sun S, 2014, Research on the Distribution Pattern and Related Factors of Common TCM Syndrome Types of Benign Prostatic Hyperplasia. Modern Chinese Medicine Clinical Practice, 21(6): 16–18.
Xu Z, Zhang M, Su M, et al., 2024, Investigation on TCM Constitution Identification and Analysis of Risk Factors for Clinical Progression in Patients With Benign Prostatic Hyperplasia. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 34(11): 35–38.
Gao Q, Zhao J, Yu G, et al., 2013, Guo Jun, Four-Type Theory and Treatment Retention of Urine Clinical Experience. Global Journal of Traditional Chinese Medicine, 6(11): 845–846.
Pan X, 2017, Syndrome Classification and Key Points of Syndrome Differentiation of Benign Prostatic Hyperplasia, thesis, Henan University of Chinese Medicine.
Chen S, Zhao R, 2012, Analysis of TCM Syndrome Types and Medication Patterns of Benign Prostatic Hyperplasia. Journal of Liaoning University of Traditional Chinese Medicine, 14(9): 137–139.
Yuan Y, Fu X, Zhu W, et al., 2018, The Effect of Yiqi Huoxue Xiaozhi Formula on Apoptosis in Rats With Benign Prostatic Hyperplasia. China Journal of Information on Traditional Chinese Medicine, 25(9): 52–55.